Updated insights into the T cell-mediated immune response against SARS-CoV-2: a step towards efficient and reliable vaccines

M Dhawan, AA Rabaan, MMA Fawarah, SA Almuthree… - Vaccines, 2023 - mdpi.com
The emergence of novel variants of SARS-CoV-2 and their abilities to evade the immune
response elicited through presently available vaccination makes it essential to recognize the …

[HTML][HTML] SARS-CoV-2 ORF3a sensitizes cells to ferroptosis via Keap1-NRF2 axis

L Liu, J Du, S Yang, B Zheng, J Shen, J Huang, L Cao… - Redox biology, 2023 - Elsevier
Viral infection-induced cell death has long been considered as a double-edged sword in the
inhibition or exacerbation of viral infections. Patients with severe Coronavirus Disease 2019 …

Neutralizing type I interferon autoantibodies in Japanese patients with severe COVID-19

S Eto, Y Nukui, M Tsumura, Y Nakagama… - Journal of Clinical …, 2022 - Springer
Purpose Autoantibodies (aAbs) to type I interferons (IFNs) have been found in less than 1%
of individuals under the age of 60 in the general population, with the prevalence increasing …

[PDF][PDF] Studi literatur: Tinjauan pemeriksaan laboratorium pada pasien COVID-19

R Mus, T Thaslifa, M Abbas, Y Sunaidi - Jurnal Kesehatan …, 2021 - academia.edu
ABSTRAK Latar Belakang: Penyakit Corona virus 19 (COVID‑19) yang disebabkan oleh
SARS‑COV‑2 terjadi melalui droplet dengan menyerang saluran pernafasan melalui …

Lung histopathological findings in COVID-19 disease–a systematic review

G Pannone, VCA Caponio, IS De Stefano… - Infectious Agents and …, 2021 - Springer
Since December 2019, the global burden of the COVID-19 pandemic has increased rapidly
and has impacted nearly every country in the world, affecting those who are elderly or with …

Mechanisms of immunothrombosis in COVID-19

I Portier, RA Campbell, F Denorme - Current opinion in …, 2021 - journals.lww.com
Mechanisms of immunothrombosis in COVID-19 : Current Opinion in Hematology
Mechanisms of immunothrombosis in COVID-19 : Current Opinion in Hematology Log in or …

A longitudinal study of immune cells in severe COVID-19 patients

D Payen, M Cravat, H Maadadi, C Didelot… - Frontiers in …, 2020 - frontiersin.org
Little is known about the time-dependent immune responses in severe COVID-19. Data of
15 consecutive patients were sequentially recorded from intensive care unit admission …

Pathological aspects of COVID-19 as a conformational disease and the use of pharmacological chaperones as a potential therapeutic strategy

T Aoe - Frontiers in pharmacology, 2020 - frontiersin.org
Coronavirus disease 2019 (COVID-19), the seventh human coronavirus infectious disease,
was first reported in Wuhan, China, in December 2019, followed by its rapid spread globally …

A systematic meta‐analysis of immune signatures in patients with COVID‐19

K Liu, T Yang, XF Peng, SM Lv, X Ye… - Reviews in Medical …, 2021 - Wiley Online Library
Currently severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) transmission has
been on the rise worldwide. Predicting outcome in COVID‐19 remains challenging, and the …

SARS‐CoV‐2‐mediated immune system activation and potential application in immunotherapy

Y Tan, F Tang - Medicinal research reviews, 2021 - Wiley Online Library
Although novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)‐mediated
pulmonary inflammation has recently attracted great attention, its pathology and …